RedHill Biopharma Ltd. Files Notice for Annual Shareholder Meeting

TL;DR

RHBP shareholders: AGM notice is out, check your proxy materials.

AI Summary

RedHill Biopharma Ltd. filed a Form 6-K on August 13, 2024, to report its notice and proxy statement for its upcoming annual general meeting of shareholders. The filing indicates the company is a foreign private issuer and will file its annual reports under Form 20-F.

Why It Matters

This filing provides shareholders with essential information regarding the upcoming annual general meeting, including voting procedures and company matters to be discussed.

Risk Assessment

Risk Level: low — This is a routine administrative filing related to an upcoming shareholder meeting, not a material event impacting the company's operations or financials.

Key Players & Entities

• RedHill Biopharma Ltd. (company) — Registrant
• 20240813 (date) — Filing Date
• Form 6-K (document) — Filing Type
• Form 20-F (document) — Annual Report Form

FAQ

Filing Documents

• zk2431835.htm (6-K) — 129KB
• image00001.jpg (GRAPHIC) — 5KB
• image00002.jpg (GRAPHIC) — 1KB
• image00003.jpg (GRAPHIC) — 2KB
• image00004.jpg (GRAPHIC) — 4KB
• 0001178913-24-002560.txt ( ) — 148KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. REDHILL BIOPHARMA LTD. (the "Registrant") Date: August 13, 2024 By: /s/ Dror Ben-Asher Name: Dror Ben-Asher Title: Chief Executive Officer REDHILL BIOPHARMA LTD. 21 Ha'arba'a Street Tel-Aviv 6473921 Israel NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS To be held on September 17, 2024 The Annual General Meeting of Shareholders of RedHill Biopharma Ltd. (the " Company "), will be held at the offices of the Company, 21 Ha'arba'a Street, Tel-Aviv, Israel, on September 17, 2024, at 15:00 p.m. Israel time, or at any adjournments thereof (the " General Meeting "), for the following purposes: 1. To appoint Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the Company's auditors for the year 2024 and for an additional period until the next Annual General Meeting; and to inform the shareholders of the aggregate compensation paid to the auditors for the year ended December 31, 2023; 2. To approve the re-election of Mr. Eric Swenden and Mr. Ofer Tsimchi and approve the election of Dr. Roni Mamluk to the board of directors of the Company (the " Board of Directors "), each for an additional three-year term until the annual general meeting to be held in 2027; 3. To approve the grant of restricted share units (" RSUs ") each with respect to one American Depository Shares (each representing 400 ordinary shares, par value NIS 0.01 each) (" ADSs ") to the non-executive directors of the Company; 4. To approve the grant of RSUs to Mr. Dror Ben-Asher, the Company's Chief Executive Officer and Chairman of the Board of Directors; and 5. To approve the grant of RSUs to Mr. Rick D. Scruggs, the Company's Chief Commercial Officer, and Director. In addition, shareholders at the General Mee

View Full Filing

View this 6-K filing on SEC EDGAR